Medicale Corp. financial data

Symbol
MCLE on OTC
Location
9314 Forest Hill Blvd, #929, Wellington, FL
State of incorporation
Nevada
Fiscal year end
September 30
Latest financial report
10-Q - Q2 2024 - Aug 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.8 % +86.5%
Debt-to-equity -100 %
Return On Equity 87.4 % -34.9%
Return On Assets -34.9K % -11.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.92M shares 0%
Common Stock, Shares, Outstanding 5.92M shares 0%
Entity Public Float 0 USD
Common Stock, Value, Issued 592 USD 0%
Weighted Average Number of Shares Outstanding, Basic 5.92M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 5.92M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
General and Administrative Expense 53.4K USD +43.9%
Operating Income (Loss) -53.4K USD -43.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -55.6K USD -49.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -55.6K USD -49.1%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 159 USD 0%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Assets 159 USD 0%
Liabilities, Current 14.1K USD -47%
Liabilities 82.2K USD
Retained Earnings (Accumulated Deficit) -159K USD -53.7%
Stockholders' Equity Attributable to Parent -82.1K USD -210%
Liabilities and Equity 159 USD 0%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -48.2K USD -30406%
Net Cash Provided by (Used in) Financing Activities 48.2K USD +789%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 5.92M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 159 USD 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 24.7K USD +46.2%
Deferred Tax Assets, Operating Loss Carryforwards 24.7K USD +46.2%
Additional Paid in Capital 76.3K USD 0%
Amortization of Intangible Assets 2.4K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD